Ensysce Biosciences, Inc.
ENSC • NASDAQ • Stock Fundamentals
Ensysce Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO D. Lynn Kirkpatrick, with a market cap of $4.5M.
Market Cap$4.5M
Employees8.0
CEOD. Lynn Kirkpatrick
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Ensysce Biosciences, Inc. FAQ
Common questions about Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. (ENSC) has a market capitalization of $4.5M and trades on NASDAQ.
Ensysce Biosciences, Inc. has approximately 8 employees.